Topical and systemic antifungal therapy for chronic rhinosinusitis.

CONCLUSIONS: Due to the very low quality of the evidence, it is uncertain whether or not the use of topical or systemic antifungals has an impact on patient outcomes in adults with chronic rhinosinusitis compared with placebo or no treatment. Studies including specific subgroups (i.e. AFRS) are lacking.
PMID: 30199594 [PubMed - as supplied by publisher]

Source: Cochrane Database of Systematic Reviews - September 10, 2018 Category: General Medicine Authors: Head K, Sharp S, Chong LY, Hopkins C, Philpott C Tags: Cochrane Database Syst Rev Source Type: research